Epitope Editing Prevents Off-Tumor Toxicity of CAR T-cell Therapy in AML

Article navigation

Research Watch| November 01 2023

Online ISSN: 2159-8290

Print ISSN: 2159-8274

2023

American Association for Cancer Research

Cancer Discov (2023) 13 (11): 2302.

Abstract

Epitope editing of hematopoietic stem and progenitor cells (HSPC) improves CAR T-cell efficacy in AML.

2023

American Association for Cancer Research

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.